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Previous studies found that NG-monomethyl-L-arginine (L-NMMA) treatment inhibits progression of 
osteoarthritis. Here, we aimed to explore the effects of L-NMMA on chondrocyte apoptosis and Bax and 
Bcl-2 mRNA expression in rabbits with knee osteoarthritis. Knee osteoarthritis was induced in 24 
healthy rabbits by Hulth method, and rabbits were randomly divided into control (n = 12) and 
experimental (n = 12) groups. Once weekly, knee joints of control rabbits were injected with saline 
solution, while knees of experimental rabbits were injected with L-NMMA. Knee joint samples were 
collected after 6 weeks of treatment. Apoptosis of chondrocytes was detected by terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and Bax and Bcl-2 mRNA expression by 
in situ hybridization. The results show that the mean rate of chondrocyte apoptosis in knees of the 
experimental rabbits was significantly lower than that of the control rabbits (P<0.05). Additionally, Bax 
expression decreased and Bcl-2 expression increased in the experimental group (P<0.05). In brief, L-
NMMA can inhibit apoptosis of joint chondrocytes through changes in the expression of apoptosis-
related genes. Thus, this molecule offers the potential for treating osteoarthritis. 
 





Osteoarthritis (OA) is a chronic, progressive 
osteoarthropathy that poses a health hazard in aging 
individuals. OA pathology includes articular cartilage 
degeneration, characterized by degradation of cartilage 
matrix and reduction in chondrocytes (Lories and Luyten, 
2011). One report analyzing the ultrastructure of cartilage 
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number of degraded chondrocytes to disease severity. A 
subsequent study of a rabbit knee OA model by 
Hashimoto et al. (1998), reported an increase in 
apoptosis of chondrocytes with accompanying pannus 
formation; specifically, 28.7% of chondrocytes were 
apoptotic in OA-affected articular cartilage. Further, 
apoptotic cells were located in the cartilage surface and 
middle layer. In contrast, only 6.7% of chondrocytes were 
apoptotic in normal cartilage, located only in the cartilage 
surface. Similarly, using TUNEL and flow cytometry, 
Blanco et al. (1998)
 
determined that apoptotic cells 





2 to 4% of normal cartilage. Staining of cartilage sections 
confirmed the presence of apoptotic cells in both the 
surface and middle layer, as well as identifying 
proteoglycan depletion. Indeed, the number of apoptotic 
cells was significantly and positively correlated with OA 
severity.  
In a follow-up study, the same group induced apoptosis 
of rabbit articular chondrocytes using varying 
concentrations of sodium nitroprusside over different time 
periods. They found that the exogenous nitric oxide (NO) 
produced by sodium nitroprusside induced apoptosis of 
cultured chondrocytes, indicating that NO plays an 
important role in chondrocyte apoptosis (Blanco et al., 
1995). Injecting collagenase into upper compartments of 
the bilateral temporomandibular joints, Gao et al. (2003) 
established a goat OA model. They then injected the 
joints with 0.5 ml of 0.5% L-monomethyl-arginine (L-
NMMA), an NO synthase inhibitor, in 3-day intervals. After 
one week OA progression was inhibited in L-NMMA-
treated joints, likely by indirect inhibition of NO synthesis. 
However, additional studies are needed to confirm the 
inhibitive effect of L-NMMA on chondrocyte apoptosis. 
Here, we investigated the mechanisms behind the 
therapeutic effects of L-NMMA on OA in rabbit knees by 




MATERIALS AND METHODS  
 
Experimental animals  
 
Twenty-four healthy adult New Zealand rabbits of both sexes were 
obtained from the Experimental Animal Center of Wuhan University. 
Rabbits weighed from 2.8 to 3.5 kg, with a mean body weight of 3.2 
± 0.2 kg. These were caged for one week before experimentation to 
assure no obvious abnormalities were observed before inclusion. 
Laboratory temperature was 22 ± 2°C with relative humidity of 60%. 
Rabbits were fed regular diets with free access to water.  
Rabbit knee OA models were established as in previous studies 
(Hulth et al., 1970). Briefly, skin on the right knee was shaved one 
day before modeling. Prior to surgery, rabbits were anesthetized 
with 3% amyl sodium pentobarbital (30 mg/kg) via ear vein, and 
then incised from the patella medial site. The medial collateral 
ligament was cut to open the knee joint cavity, then the anterior and 
posterior cruciate ligaments were cut with ophthalmic scissors and 
the medial meniscus was resected. Surgery did not damage the 
articular cartilage surface. After complete hemostasis, the wound 
was sutured by layer. Limb fixation was not needed after surgery. 
Rabbits were randomized to either the control or experimental 
groups, with 12 in each group. One week after surgery, rabbits were 
treated with either 0.3 ml saline (control) or 0.3 ml 0.5% L-NMMA 
(experimental; Sigma Chemical Co., St. Louis, MO) via cavity 
puncture of the right knee joint once per week. After 6 weeks of 
treatment, rabbits were killed by air embolism, the right knees were 
opened, and the lateral tibial plateau of the right upper end was 
removed. Samples were fixed and paraffin embedded for serially 
sectioning with thickness of 4 µM.  
 
 
Terminal deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL)  
 
TUNEL reactions were  performed  according to the  manufacturer’s  




instructions, with some modifications (Roche, Mannheim, 
Germany). Briefly, sections were dewaxed prior to digestion with 20 
mg/ml trypsin for 15 min at room temperature. Following treatment 
with 3% H2O2 solution for 5 min, slides were placed in 50 µL 
balanced fluid for 1 min, to which 15 µL reaction solution containing 
TDT enzyme was added. Reaction proceeded at 37°C for 1.5 h 
before being stopped with reaction-termination solution. Slides were 
rinsed with buffer solution twice for 15 min each. Slides were 
incubated with 20 ml/L normal goat serum for 30 min and then anti-
digoxigenin alkaline phosphatase antibody in a humid chamber for 
2 h. Following rinses with buffer 1 and buffer 3, freshly-prepared 
DAB color reagent was added to develop the color. After 
visualization, color development was halted, slides were washed 
and stained with hematoxylin and finally sealed with neutral gum.  
 
 
In situ hybridization (ISH)  
 
Bax and Bcl-2 in situ hybridization detection kits were purchased 
from Invitrogen Life Technologies, Inc. (Carlsbad, CA, US). 
Following dewaxing and treatment with 3% H2O2 solution for 10 min 
at room temperature, samples were digested for 5 min by pepsase 
diluted with 3% citric acid. Then 20 µL pre-hybridization solution 
were added and slides were placed in a humidified chamber for 
incubation at 37°C for 2 h. Next, 20 µL hybridization solution were 
then added and slides were incubated at 37°C overnight. Following 
incubation with blocking solution at 37°C for 30 min, slides were 
treated with biotinylated mouse anti-digoxigenin at 37°C for 60 min. 
Streptavidin--biotin complex (SABC) was incubated on slides at 
37°C for 20 min, then biotinylated peroxidase was added for 20 
min, and finally 3,3´-diaminobenzidine (DAB) was used to develop 
color for 10 min. Slides were rinsed with tap water for 10 min and 
then stained with hematoxylin and sealed with neutral gum. Positive 
staining results were interpreted as appearance of brown tinting in 
the cytoplasm and nucleus. Sections without probes were used as 
negative control. Staining was visualized under light microscope 
(400×) and analyzed with Image-pro Plus6.0 image processing 
system (Media Cybernetics, Inc. Bethesda, MD, US). Ten different 
fields were selected for each section. Bax and Bcl-2 mRNA 
expression in chondrocytes was assessed by positive area and 
grayscale values (maximum grayscale was set as 255 for white, 
and minimum grayscale was set as 0 for black; smaller grayscale 
indicates higher intensity of positive reaction/expression).  
 
 
Statistical methods  
 
SPSS13.0 statistical software was used for statistical analysis. 
Results are expressed as mean± standard deviation. Independent 
sample χ
2
 test was used to compare apoptosis of chondrocytes or 
Bax and Bcl-2 mRNA expression between different groups. Two-






Reduced apoptosis of chondrocytes following L-
NMMA treatment  
 
In both L-NMMA-treated and untreated OA rabbit knees, 
apoptotic nuclei appeared brown and were mainly 
distributed in the cartilage proliferation zone and shallow 
layer of hypertrophic cells. In the control group, 12.05 ± 
1.17%  of    chondrocytes     was     apoptotic,   primarily 







Figure 1. Altered expression of Bax and Bcl-2 mRNA in chondrocytes following L-NMMA treatment. A, Expression area; 




concentrated in the cartilage proliferation zone. However, 
in experimental rabbits treated with L-NMMA, the number 
of apoptotic cells was significantly reduced [5.09 ± 
0.31%, t=19.851, P=0.001] and cartilage chondrocyte 
layers were maintained.  
 
 
Altered Bax and Bcl-2 expression following L-NMMA 
treatment  
 
We next explored the mechanism behind this decreased 
apoptosis following L-NMMA treatment. Using image 
analysis software to quantify ISH signals, we measured 
the mRNA expression area of apoptosis-related genes 
Bax (pro-apoptotic) and Bcl-2 (anti-apoptotic). Mean Bax 
expression area was reduced following L-NMMA 
treatment measured as 912.22 ± 50.99 in the controls 
and 728.39 ± 26.00 in the experimental rabbits (Figure 
1A). Mean expression areas of Bcl-2 were 693.65 ± 
32.36 and 958.23 ± 38.95 in the control and experimental 
groups, respectively (Figure 1B). Thus, the ratio of 
Bax/Bcl-2 expression area was significantly altered from 
(0.76 ± 0.06) in the controls to (1.32 ± 0.09) in the 
experimental group (Figure 1C, t = 18.182, P = 0.001). 
Statistical analysis showed that compared with the control 
group, the expression area of Bax in experimental group 
was significantly reduced (t = 18.327, P = 0.001), while 
Bcl-2 expression area was significantly increased (t = 
11.126, P = 0.001). 
Expression intensity of Bax and Bcl-2 in chondrocytes 
was measured via ISH grayscale values (higher value = 
less intensity). Grayscale values for Bax expression were 
157.88 ± 7.79 and 184.37 ± 7.36 in the control and 
experimental groups, respectively reflecting a significant 
increase in Bax expression in the experimental group 
(Figure 1B; t = 8.566, P = 0.001). Grayscale values for 
Bcl-2 were (190.88 ± 20.17) and (149.13 ± 7.83), 
respectively for the control and experimental groups, 
reflecting a significant reduction in Bcl-2 expression in 
experimental rabbit knees (Figure 1B; t = 6.687, P = 
0.001). The ratio of Bcl-2/Bax grayscale intensity was 
therefore 1.21 ± 0.15 for the controls and 0.81 ± 0.06 for 
the experimental rabbits, with a statistically significant 





The pathogenesis of OA is characterized by degenerative 





adjacent cartilage and ossification. Recent studies of OA 
pathogenesis mainly focused on apoptosis of the 
chondrocyte itself (Ishoguro et al., 2002; Loeser, 2006). 
Farrell et al. (1992) found that a large amount of the NO 
metabolite nitrite could be detected in synovial fluid and 
serum of OA patients, suggesting that NO may be 
involved in the pathology of OA. Meanwhile, in vitro 
studies (2005) found that high concentrations of NO 
cause apoptosis or necrosis of chondrocytes. Thus, 
inhibition of chondrocyte apoptosis by preventing NO 
production may offer a new approach in treating OA. In 
addition, two molecules, L-NMMA and L-arginine, may 
compete for NO synthase binding sites, thereby inhibiting 
NO synthase and indirectly preventing NO production. In 
a study by Amin et al. (2000)
 
in which L-NMMA was used 
to treat arthritis, L-NMMA effectively reduced NO, 
ameliorating arthritis swelling and tissue damage. 
Similarly, administering L-NMMA to OA rat models by 
intraperitoneal injection resulted in reduced swelling and 
redness (McCartney-Francis et al., 2001).  
Here, we used a rabbit knee OA model to investigate 
the mechanisms behind the effects of L-NMMA treatment. 
TUNEL staining revealed an obvious decrease in 
apoptosis of chondrocytes, with a corresponding increase 
in expression of Bcl-2 (anti-apoptotic) and decrease in 
Bax (pro-apoptotic) expression. Thus, in inhibiting NO 
synthase, L-NMMA can inhibit apoptosis of knee 
chondrocytes, thus resulting in a protective effect 
whereby degeneration of articular cartilage is delayed. 
However, the repair of cartilage defects is a regulatory 
process involving multiple factors, and inhibition of 
excessive release of NO is only one aspect of this 
process. NO is a signal transmission molecule with broad 
functions in the body, and normal physiological 
concentrations of NO may be interrupted by L-NMMA 
administration, potentially producing serious side-effects  
(McCartney-Francis et al., 2003). Therefore, further 
studies on NO inhibitors are needed to develop more 
specific drugs before these molecules can be used as 
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